OsseoLabs
Merging 3D-Printing, AI, and Biomechanics to Revolutionize Personalized Surgical Solutions
Indianapolis, United States · Founded 2021 · $8.9M raised
- Headquarters
- Indianapolis, Indiana
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- osseolabs.com
- Total Funding
- $8.9M
- Last Round
- $6.9M GrantAug 2025
- Rounds
- 2
About
OsseoLabs is at the forefront of revolutionizing surgical procedures through the integration of 3D printing technology and artificial intelligence. Specializing in bespoke medical devices, OsseoLabs offers personalized surgical solutions for maxillofacial and orthopedic surgeries, with technology pillars including OsseoVision (AI-driven surgical planning), OsseoMatrix (porous scaffold architecture), OsseoOptimize (implant performance engineering), and a bioresorbable metal implant platform. Founded in 2021, the company is headquartered in Bloomington, Indiana with an additional location in Bangkok, Thailand. OsseoLabs raised a $1.4M seed round in June 2023 and has won recognition including Best Healthtech Startup at GSA Southeast Asia.
Summary
OsseoLabs is a Healthcare company based in Indianapolis, United States, founded in 2021. It has raised $8.9M in total across 2 rounds, most recently a $6.9M Grant round in Aug 2025. Investors include Johnson & Johnson Innovation, Plug and Play and Texas Medical Center.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
